Companies /Merck News

All Themes

Business

Education

Court Upholds Class Action Suit Against Merck

AHN

Denise Royal - AHN Staff Writer New York, NY (AHN) - In a significant legal and financial setback for Merck and Company, an appeals court has ruled a class-action lawsuit over Vioxx can proceed. The ruling lets insurers and others sue to recover the billions of dollars they spent on the drug....

Court upholds Vioxx class action against Merck

YAHOO

Reuters - A New Jersey appellate court on Friday upheld a judge's decision to certify a national class action against Merck & Co. Inc. for some cases involving the drugmaker's withdrawn pain medicine Vioxx, attorneys representing plaintiffs said.

Schering Embraces $19.6B Bid by Bayer

YAHOO

AP - Bayer AG's 16.3 billion euro ($19.6 billion) offer for drugmaker Schering AG was embraced enthusiastically by its target Friday as German rival Merck abandoned its own takeover offer.

Schering supports Bayer drug bid

BBC

German drugs firm Bayer makes a $19.5bn bid for Schering, after the latter rejects a bid from Merck.

Bayer Makes $19.5B Offer for Schering

YAHOO

AP - German pharmaceutical and chemical company Bayer AG said Thursday it would make a 16.3 billion euro ($19.5 billion) white-knight offer for Schering AG, bidding against a hostile takeover effort from Merck KgA.

	Categories		Latest Merck News		Related:
	Microsoft LG Companies Links Trade links		Court hearing Vioxx case evacuated in alert YAHOO Reuters - A courthouse in Atlantic City where a case is being heard against drug company Merck & Co. over pain-relieving drug Vioxx was evacuated on Wednesday after a suspicious device was found. Sources: YAHOO Merck to make formal bid for Schering in April YAHOO AFP - German drug maker Merck is to make a formal offer for rivals Schering next month, Merck boss Michael Roemer said in a newspaper interview. Sources: YAHOO Schering's Board to Discuss Merck's Bid YAHOO AP - German drugmakers Merck KGaA and Schering AG sparred Tuesday over Merck's unsolicited 14.9 billion euro ($17.7 billion) takeover that would, if successful, create Germany's second-biggest pharmaceutical company. Sources: YAHOO Untying Merck deal may cost Astra $3.3 bln in 2008 YAHOO Reuters - AstraZeneca Plc said on Tuesday it expected to pay a net $3.3 billion to Merck & Co Inc in 2008 if the U.S. group opts to sell back rights to certain drugs marketed in the United States. Sources: YAHOO Lufthansa CFO Resigns AHN Julie Farby - AHN Staff Writer Frankfurt, Germany (AHN)— The airline company Lufthansa AG announces that its chief financial officer, Karl-Ludwig Kley, will resign this month to take a position with the German drugmaker Merck. The German-based airline says CFO Kley told the ompany's... Sources: AHN Schering Shares Soar on Merck Buyout Offer YAHOO AP - Shares of Schering AG soared 26 percent Monday after rival German drugmaker Merck KGaA's unsolicited offer to buy the company for 14.6 billion euros ($17.4 billion). Sources: YAHOO Merck in 14.6-bln-euro hostile takeover bid for Schering YAHOO AFP - Merck KGaA, the German maker of pharmaceuticals and specialty chemicals, said it was launching a hostile bid worth 14.6 billion euros (17.7 billion dollars) to buy Berlin-based rival Schering. Sources: YAHOO Merck in $17.4-bln bid for Schering YAHOO Reuters - German drugs and chemicals group Merck said on Monday it will offer 14.6 billion euros ($17.4 billion) in cash for domestic rival Schering, marking the first big all-German consolidation step in the industry. Sources: YAHOO Schering says Germany's Merck plans $18 bln bid YAHOO Reuters - Germany's Merck KGaA intends to make an unsolicited takeover bid for Schering at 77 euros a share, Schering said on Sunday, adding that the offer significantly undervalued it and that no talks were on. Sources: YAHOO Merck rushed Vioxx development, court told YAHOO Reuters - Merck & Co. Inc. accelerated development of its Vioxx pain drug because it calculated it could lose more than $600 million a year if it did not beat competitors to market, a court heard on Tuesday. Sources: YAHOO Merck tried to hide Vioxx risk: attorney YAHOO Reuters - Merck & Co. knew its painkiller Vioxx significantly increased the risk of heart attack but worked to hide the evidence from doctors, patients and the scientific community to boost profits, a lawyer for a former Vioxx user argued on Monday. Sources: YAHOO Authors stand by criticized Merck Vioxx study YAHOO Reuters - Authors of a key study on the safety of Merck & Co.'s arthritis medicine Vioxx on Wednesday defended themselves from critics who claim the study inappropriately excluded three heart attacks among patients who took the drug, which has since been withdrawn. Sources: YAHOO US jury finds Merck not liable for death of Vioxx user YAHOO AFP - A US federal jury has decided US pharmaceutical giant Merck and Co. is not liable for the 2001 death of a Florida man who had taken the company's Vioxx pain medication. Sources: YAHOO Federal Vioxx jury says Merck not liable in death YAHOO Reuters - A federal jury said on Friday that drugmaker Merck Co. Inc. was not liable in the 2001 death of a Florida man who used the recalled painkiller Vioxx. Sources: YAHOO Jury Clears Merck in Vioxx Federal Trial YAHOO AP - A federal jury on Friday handed Merck & Co. a major victory when it cleared the drug maker of any responsibility in the death of a 53-year-old Florida man who had a heart attack after taking its once popular painkiller Vioxx for less than a month. Sources: YAHOO Jury Clears Merck in Vioxx Federal Trial YAHOO AP - A federal jury handed Merck & Co. a major victory when it cleared the drug maker of any responsibility in the death of a 53-year-old Florida man who had a heart attack after taking its once popular painkiller Vioxx for less than a month. Sources: YAHOO Jury reaches verdict in federal Vioxx case YAHOO Reuters - A federal judge said a jury reached a verdict on Friday afternoon in a federal court trial alleging that Merck & Co. Inc.'s recalled painkiller Vioxx caused the death of someone who took it. Sources: YAHOO FDA: Merck Had Time to Warn About Vioxx YAHOO AP - Merck & Co. could have warned that its popular painkiller Vioxx might increase the risk of heart attacks as soon as the first evidence showed up, rather than waiting two years for federal approval, a former Food and Drug Administration official testified Friday. Sources: YAHOO AP: Journal Editors Dispute Merck Claim YAHOO AP - The New England Journal of Medicine demanded changes before publishing results of the study that led Merck and Co. to pull the painkiller Vioxx from the market, and one of its top editors disputes the way the drugmaker is using it as a pillar of its legal defense in liability suits. Sources: YAHOO AP: Journal Editors Dispute Merck Claim YAHOO AP - The New England Journal of Medicine demanded changes before publishing results of the study that led Merck and Co. to pull the painkiller Vioxx from the market, and one of its top editors disputes the way the drugmaker is using it as a pillar of its legal defense in liability suits. Sources: YAHOO		Other aggregators

Pages:

[1] [2] [3] [4] [5]

Add Merck headlines to your website!